---
figid: PMC4768650__coaci-16-186-g003
figtitle: Eosinophils contain and/or release a wide array of preformed and de novo
  synthesized mediators important for their effector functions
organisms:
- Homo sapiens
- Mus musculus
- Nicotiana tabacum
pmcid: PMC4768650
filename: coaci-16-186-g003.jpg
figlink: /pmc/articles/PMC4768650/figure/F2/
number: F2
caption: Eosinophils contain and/or release a wide array of preformed and de novo
  synthesized mediators important for their effector functions. Specific granules
  contain several cationic proteins, including MBP, ECP, EDN, and EPX. Eosinophils
  can degranulate by exocytosis or by piecemeal degranulation whereby individual granule
  contents are differentially secreted by activated eosinophils without disruption
  of the cell membrane. Sombrero vesicles are morphologically distinct vesicles that
  carry granules to the plasma membrane. Lipid bodies are structurally distinct sites
  within eosinophils that are responsible for synthesis of eicosanoid mediators of
  inflammation []. Eosinophils produce numerous chemokines, cytokines, growth and
  angiogenic factors that mediate allergic inflammation, fibrosis, and thrombosis.
  Eosinophils generate extracellular DNA traps [] and secrete exosomes []. A nonexhaustive
  list of these products is shown in boxes. ECP, eosinophil cationic protein; EDN,
  eosinophil-derived neurotoxin; EPX, eosinophil peroxidase; MBP, major basic protein;
  PAF, platelet activating factor; PDGF, platelet-derived growth factor; SCF, stem
  cell factor; TF, tissue factor; TGF, transforming growth factor; VEGF, vascular
  endothelial growth factor.
papertitle: 'Interleukin-5 pathway inhibition in the treatment of eosinophilic respiratory
  disorders: evidence and unmet needs.'
reftext: Gilda Varricchi, et al. Curr Opin Allergy Clin Immunol. 2016 Apr;16(2):186-200.
year: '2016'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.7608343
figid_alias: PMC4768650__F2
figtype: Figure
organisms_ner:
- Homo sapiens
- Mus musculus
redirect_from: /figures/PMC4768650__F2
ndex: e9025838-dea0-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4768650__coaci-16-186-g003.html
  '@type': Dataset
  description: Eosinophils contain and/or release a wide array of preformed and de
    novo synthesized mediators important for their effector functions. Specific granules
    contain several cationic proteins, including MBP, ECP, EDN, and EPX. Eosinophils
    can degranulate by exocytosis or by piecemeal degranulation whereby individual
    granule contents are differentially secreted by activated eosinophils without
    disruption of the cell membrane. Sombrero vesicles are morphologically distinct
    vesicles that carry granules to the plasma membrane. Lipid bodies are structurally
    distinct sites within eosinophils that are responsible for synthesis of eicosanoid
    mediators of inflammation []. Eosinophils produce numerous chemokines, cytokines,
    growth and angiogenic factors that mediate allergic inflammation, fibrosis, and
    thrombosis. Eosinophils generate extracellular DNA traps [] and secrete exosomes
    []. A nonexhaustive list of these products is shown in boxes. ECP, eosinophil
    cationic protein; EDN, eosinophil-derived neurotoxin; EPX, eosinophil peroxidase;
    MBP, major basic protein; PAF, platelet activating factor; PDGF, platelet-derived
    growth factor; SCF, stem cell factor; TF, tissue factor; TGF, transforming growth
    factor; VEGF, vascular endothelial growth factor.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MBP
  - MBL2
  - PRG2
  - RNASE3
  - RNASE2
  - EDN1
  - EDN2
  - EDN3
  - EPX
  - CCL5
  - CCL11
  - CCL24
  - CCL26
  - CCL13
  - C5
  - CXCL1
  - KITLG
  - IL12A
  - IL12B
  - IL2
  - IFNG
  - IL5
  - IL10
  - TNF
  - IL4
  - IL6
  - IL13
  - CSF2
  - VEGFA
  - VEGFB
  - CCL2
  - CCL3
  - CCL17
  - ADAM11
  - CCL22
  - CCL23
  - CXCL5
  - CXCL8
  - CXCL9
  - CXCL10
  - CXCL11
  - IL25
  - IL1B
  - IL3
  - IL11
  - IL17A
  - IL16
  - TNFSF13
  - ANP32B
  - IL1A
  - MYDGF
  - ANGPT1
  - ANGPT2
  - ANGPT4
  - AREG
  - BDNF
  - CSF1
  - EFNA1
  - EFNA2
  - EFNA3
  - EFNA4
  - EFNA5
  - EGF
  - EREG
  - FGF1
  - FGF10
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF2
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FLT3LG
  - HGF
  - IGF1
  - IGF2
  - INS
  - NGF
  - NTF3
  - NTF4
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - PGF
  - TGFA
  - VEGFC
  - VEGFD
  - TGFB1
  - TGFB2
  - TGFB3
  - NEUROD1
  - TUBB4B
  - PCLAF
  - TF
  - TRAP
  - ACP5
  - CD40LG
  - TRAF2
  - TRRAP
  - TDRD7
  - SCYL1
  - Mbp
  - Prg2
  - Ear2
  - Epx
  - Ccl5
  - Ccl11
  - Mcpt4
  - Cxcl1
  - Kitl
  - Il2
  - Ifng
  - Il5
  - Il10
  - Csf2
  - Tnf
  - Il4
  - Il6
  - Il13
  - Vegfa
  - Vegfb
  - Ccl2
  - Ccl3
  - Ccl17
  - Adam11
  - Ccl22
  - Cxcl5
  - Cxcl15
  - Cxcl9
  - Cxcl10
  - Cxcl11
  - Il25
  - Il1b
  - Il3
  - Il11
  - Il17a
  - Il16
  - Tnfsf13
  - Il1a
  - Ngf
  - Pdgfb
  - Tgfb1
  - Ltbp1
  - Tgfa
  - Hbb-b2
  - Neurod1
  - Paf
  - Pclaf
  - Il1
  - Acp5
  - Ssr4
  - Cd40
  - Cd40lg
  - 15-HETE
  - Prostaglandins
  - PGE
  - Thromboxane B2
  - PGE2
  - Leukotrienes
---
